scispace - formally typeset
Journal ArticleDOI

The national high blood pressure education program.

John B. Stokes
- 01 Apr 1974 - 
- Vol. 14, Iss: 4, pp 172-176
About
This article is published in Journal of the American Pharmaceutical Association.The article was published on 1974-04-01. It has received 1110 citations till now. The article focuses on the topics: Health education.

read more

Citations
More filters
Journal ArticleDOI

Early exposure to toxic metals has a limited effect on blood pressure or kidney function in later childhood, rural Bangladesh

TL;DR: There is some evidence that arsenic exposure in early life has long-term consequences for blood pressure and maybe kidney function, and no association was observed between early arsenic or cadmium exposure and kidney volume at 4.5 years.
Journal ArticleDOI

Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up.

TL;DR: Antenatal steroid administration, maternal hypertension, umbilical arterial catheter, postnatal acute renal failure, patent ductus arteriosus, indomethacin treatment and chronic lung disease were associated with the development of neonatal hypertension.
Journal ArticleDOI

Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children

TL;DR: The results suggest that TAC is an effective therapeutic modality for SRNS, including the subgroup of children who are nonresponsive to the current therapeutic modalities like cyclophosphamide and cyclosporine.
Journal ArticleDOI

Cardiovascular risk factors in children with obesity, hypertension and diabetes: lipoprotein(a) levels and body mass index correlate with family history of cardiovascular disease

TL;DR: Levels of lipoprotein(a) and apolipoprotein B may be predictive of future cardiovascular disease in predisposed children in obese, hypertensive and diabetic children.
Journal ArticleDOI

Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives.

TL;DR: SPC use was associated with significantly better compliance/persistence and fewer hospitalizations and ER visits than FC in hypertensive patients at the national level and in almost all states and larger reductions in medical costs with SPC use more than offset higher drug costs within most states.